Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02006043
Brief Title: Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-)

First Submitted : November 26, 2013
First Submitted that Met QC Criteria : December 6, 2013
First Posted : December 9, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : July 1, 2015
Last Update Posted : July 3, 2015 (Estimate)